Olivia Newton-John Cancer Research Institute

OrgUnit's Researchers
(Persons)

Results 1-5 of 36 (Search time: 0.002 seconds).

FullnameTranslated NameEmail
Afshar-Sterle, ShoukatSkoukat.AFSHAR-STERLE@austin.org.au
Allan, Laura CLaura.Allan@onjcri.org.au
Anderson, Robin Lrobyn.anderson@austin.org.au
Ayati, Narjessnarjess.ayati@austin.org.au
Barraclough, AllisonAllison.BARRACLOUGH@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 141-160 of 931 (Search time: 0.013 seconds).

Publication YearTitleAuthor(s)
1411-Oct-2017Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.Gleeson, M; Counsell, Nicholas; Cunningham, D; Chadwick, N; Lawrie, A; Hawkes, Eliza A ; McMillan, A; Ardeshna, K M; Jack, A; Smith, P; Mouncey, P; Pocock, C; Radford, J A; Davies, J; Turner, D; Kruger, A; Johnson, P ; Gambell, J; Linch, D
14221-Jan-2021Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain.Ye, Zimeng; Chatterton, Zac; Pflueger, Jahnvi; Damiano, John A; McQuillan, Lara ; Harvey, Anthony Simon; Malone, Stephen; Do, Hongdo; Maixner, Wirginia; Schneider, Amy L ; Nolan, Bernadette; Wood, Martin; Lee, Wei Shern; Gillies, Greta; Pope, Kate; Wilson, Michael; Lockhart, Paul J; Dobrovic, Alexander ; Scheffer, Ingrid E ; Bahlo, Melanie; Leventer, Richard J; Lister, Ryan; Berkovic, Samuel F ; Hildebrand, Michael S 
143Mar-2020Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study.Felip, Enriqueta; de Braud, Filippo G; Maur, Michela; Loong, Herbert H; Shaw, Alice Tsang; Vansteenkiste, Johan F; John, Thomas ; Liu, Geoffrey; Lolkema, Martijn P; Selvaggi, Giovanni; Giannone, Vanessa; Cazorla, Pilar; Baum, Jason; Balbin, O Alejandro; Wang, Luojun Victor; Lau, Yvonne Y; Scott, Jeffrey W; Tan, Daniel Shao-Weng
14418-Oct-2019Ceritinib plus nivolumab in patients with advanced ALK-rearranged non-small-cell lung cancer: results of an open-label, multicenter, phase 1B study: Ceritinib plus nivolumab in ALK-rearranged NSCLC.Felip, Enriqueta; de Braud, Filippo G; Maur, Michela; Loong, Herbert H; Shaw, Alice Tsang; Vansteenkiste, Johan F; John, Thomas ; Liu, Geoffrey; Lolkema, Martijn P; Selvaggi, Giovanni; Giannone, Vanessa; Cazorla, Pilar; Baum, Jason; Balbin, O Alejandro; Wang, Luojun Victor; Lau, Yvonne Y; Scott, Jeffrey W; Shao-Weng Tan, Daniel
14521-May-2017Challenging a misnomer? The role of inflammatory pathways in inflammatory breast cancerMorrow, Riley J; Etemadi, Nima; Yeo, Belinda ; Ernst, Matthias 
146Jul-2021Changes in prescribing habits for the treatment of metastatic renal clear cell carcinoma (mRCC) in Australia.Balasubramanian, Adithya ; Qu, Liang G ; Weickhardt, Andrew J ; Bolton, Damien M ; Perera, Marlon 
147Apr-2018Characterising the phenotypic evolution of circulating tumour cells during treatment.Tsao, Simon Chang-Hao; Wang, Jing; Wang, Yuling; Behren, Andreas; Cebon, Jonathan S ; Trau, Matt
1481-Feb-2023Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study.Goh, Zhong; Latimer, Maya; Lewis, Katharine L; Cheah, Chan Y; Ciaccio, Pietro Di; Cushion, Tania; Hawkes, Eliza A ; Harrop, Sean; Ku, Matthew; Campbell, Ashlea; Hamad, Nada; Wood, Erica M; Chung, Eliza; Chen, Pin-Yen; Cochrane, Tara
14913-Jun-1996Characterization and localization of bradykinin B2 receptors in the guinea-pig using a radioiodinated HOE140 analogue.Murone, Carmel ; Perich, R B; Schlawe, I; Chai, Syn Y; Casley, David J; MacGregor, Duncan; Müller-Esterl, W; Mendelsohn, Frederick AO
150Feb-2020Characterization of a novel human BFL-1-specific monoclonal antibody.Gangoda, Lahiru; Teh, Charis E; Dengler, Michael A; Best, Sarah A; Weeden, Clare E; Tai, Lin; Lee, Erinna F; Fairlie, Walter Douglas ; Sutherland, Kate D; Harrison, Leonard C; Gray, Daniel H; Strasser, Andreas; Herold, Marco J
151Sep-2021Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.Hurley, Rachel M; McGehee, Cordelia D; Nesic, Ksenija; Correia, Cristina; Weiskittel, Taylor M; Kelly, Rebecca L; Venkatachalam, Annapoorna; Hou, Xiaonan; Pathoulas, Nicholas M; Meng, X Wei; Kondrashova, Olga; Radke, Marc R; Schneider, Paula A; Flatten, Karen S; Peterson, Kevin L; Becker, Marc A; Wong, Ee Ming; Southey, Melissa S; Dobrovic, Alexander ; Lin, Kevin K; Harding, Thomas C; McNeish, Iain; Ross, Christian A; Wagner, Jill M; Wakefield, Matthew J; Scott, Clare L; Haluska, Paul; Wahner Hendrickson, Andrea E; Karnitz, Larry M; Swisher, Elizabeth M; Li, Hu; Weroha, S John; Kaufmann, Scott H
15226-Feb-2018Characterization of ABBV-221, a Tumor-Selective EGFR Targeting Antibody Drug Conjugate.Phillips, Andrew C; Boghaert, Erwin R; Vaidya, Kedar S; Falls, Hugh D; Mitten, Michael J; DeVries, Peter J; Benatuil, Lorenzo; Hsieh, Chung-Ming; Meulbroek, Jonathan A; Panchal, Sanjay C; Buchanan, Fritz G; Durbin, Kenneth R; Voorbach, Martin J; Reuter, David R; Mudd, Sarah R; Loberg, Lise I; Ralston, Sherry L; Cao, Diana; Gan, Hui K ; Scott, Andrew M ; Reilly, Edward B
1532-Mar-2015Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody.Reilly, Edward B; Phillips, Andrew C; Buchanan, Fritz G; Kingsbury, Gillian; Zhang, Yumin; Meulbroek, Jonathan A; Cole, Todd B; DeVries, Peter J; Falls, Hugh D; Beam, Christine; Gu, Jinming; Digiammarino, Enrico L; Palma, Joann P; Donawho, Cherrie K; Goodwin, Neal C; Scott, Andrew M 
1541-Jul-2012Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancer.John, Thomas ; Yanagawa, Naoki; Kohler, Derek; Craddock, Kenneth J; Bandarchi-Chamkhaleh, Bizhan; Pintilie, Melania; Sykes, Jenna; To, Christine; Li, Ming; Panchal, Devang; Chen, Weisan; Shepherd, Frances A; Tsao, Ming-Sound
15524-Sep-2021Characterizing the Heterogeneity of Small Extracellular Vesicle Populations in Multiple Cancer Types via an Ultrasensitive Chip.Wang, Jing; Wuethrich, Alain; Lobb, Richard J; Antaw, Fiach; Sina, Abu Ali Ibn; Lane, Rebecca E; Zhou, Quan; Zieschank, Chloe; Bell, Caroline; Bonazzi, Vanessa F; Aoude, Lauren G; Everitt, Sarah; Yeo, Belinda ; Barbour, Andrew P; Möller, Andreas; Trau, Matt
15620-Dec-2017Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support.Opat, Stephen; Hawkes, Eliza A 
157Feb-2022Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis.Goldinger, Simone M; Buder-Bakhaya, Kristina; Lo, Serigne N; Forschner, Andrea; McKean, Meredith; Zimmer, Lisa; Khoo, Chloe; Dummer, Reinhard; Eroglu, Zeynep; Buchbinder, Elizabeth I; Ascierto, Paolo A; Gutzmer, Ralf; Rozeman, Elisa A; Hoeller, Christoph; Johnson, Douglas B; Gesierich, Anja; Kölblinger, Peter; Bennannoune, Naima; Cohen, Justine V; Kähler, Katharina C; Wilson, Melissa A; Cebon, Jonathan S ; Atkinson, Victoria; Smith, Jessica L; Michielin, Olivier; Long, Georgina V; Hassel, Jessica C; Weide, Benjamin; Haydu, Lauren E; Schadendorf, Dirk; McArthur, Grant; Ott, Patrick A; Blank, Christian; Robert, Caroline; Sullivan, Ryan; Hauschild, Axel; Carlino, Matteo S; Garbe, Claus; Davies, Michael A; Menzies, Alexander M
158May-2018CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.Gleeson, Mary; Peckitt, Clare; To, Ye Mong; Edwards, Laurice; Oates, Jacqueline; Wotherspoon, Andrew; Attygalle, Ayoma D; Zerizer, Imene; Sharma, Bhupinder; Chua, Sue; Begum, Ruwaida; Chau, Ian; Johnson, Peter; Ardeshna, Kirit M; Hawkes, Eliza A ; Macheta, Marian P; Collins, Graham P; Radford, John; Forbes, Adam; Hart, Alistair; Montoto, Silvia; McKay, Pamela; Benstead, Kim; Morley, Nicholas; Kalakonda, Nagesh; Hasan, Yasmin; Turner, Deborah; Cunningham, David
15910-Mar-2009Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial.Davis, Ian D; Brady, Ben; Kefford, Richard F; Millward, Michael; Cebon, Jonathan S ; Skrumsager, Birte K; Mouritzen, Ulrik; Hansen, Lasse Tengbjerg; Skak, Kresten; Lundsgaard, Dorthe; Frederiksen, Klaus Stensgaard; Kristjansen, Paul E G; McArthur, Grant A
1602023Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.Noelle, Randolph J; Lines, J Louise; Lewis, Lionel D; Martell, Robert E; Guillaudeux, Thierry; Lee, Sam W; Mahoney, Kathleen M; Vesely, Matthew D; Boyd-Kirkup, Jerome; Nambiar, Dhanya K; Scott, Andrew M